pegloticase
Term · Oncology and biomedicine · MLC-T-ONC-015912
A recombinant modified mammalian urate oxidase (uricase) conjugated to monomethoxypolyethylene glycol (mPEG), that can be used to lower serum uric acid. Upon intravenous infusion, pegloticase catalyzes the oxidation of uric acid to allantoin, thereby lowering serum uric acid. Allantoin is an inert and water-soluble purine metabolite; it is readily eliminated, primarily by renal excretion.
| Identifier | MLC-T-ONC-015912 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | methoxypolyethylene glycol uricase; polyethylene glycol-uricase |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015912",
"term": "pegloticase",
"field": "Oncology and biomedicine",
"definition": "A recombinant modified mammalian urate oxidase (uricase) conjugated to monomethoxypolyethylene glycol (mPEG), that can be used to lower serum uric acid. Upon intravenous infusion, pegloticase catalyzes the oxidation of uric acid to allantoin, thereby lowering serum uric acid. Allantoin is an inert and water-soluble purine metabolite; it is readily eliminated, primarily by renal excretion.",
"synonyms": [
"methoxypolyethylene glycol uricase",
"polyethylene glycol-uricase"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pegloticase/"
}
Record 12,854 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.